Furthermore, a new Th2 cytokine, IL-31, has major pruritogenic potency for inflammatory mediators in AD [51], and serum levels of IL-31 correlate with disease severity in AD patients [52]. This evidence concerns the gene IL31 and Alzheimer disease.